• 1
    Meakin JJ. Jaundice and blood pressure. Med Clin N Amer 1932; 16:715729.
  • 2
    Song E, Segal I, Hodkinson J, Kew MC. Sinus bradycardia in obstructive jaundice - correlation with total serum bile acid concentrations. South African Med J 1983; 64:548551.
  • 3
    Herman J. Tracing the “disappearance” of two physical signs. Perspectives Biol Med 1996; 40:5559.
  • 4
    Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953; 32:10251033.
  • 5
    Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8:11511157.
  • 6
    Harvey W. Exercitatio anatomica de motu cordis et sanguinis in animalibus. Frankfort: W. Fitzer, 1628.
  • 7
    French R. Harvey, clinical medicine and the College of Physicians. Clin Med 2002; 2:584590.
  • 8
    Newby DE, Hayes PC. Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but “splanchnic steal”. Clin J Med 2002; 95:827830.
  • 9
    Gilbert A, Villaret M. Contribution à l'étude du syndrome d'hypertension portale: cytologie des liquides d'ascite dans les cirrhoses. Compt Rend Soc Biol 1906; 60:820823.
  • 10
    Stahl GE. De vena Portæ, porta malorum hypochondriaco-splenectico-suffocativo, hysterico-colico hemorrhoidariorum. Halle, 1698.
  • 11
    Banti G. La splenomegalia con cirosi del fegato. Lo Sperimentale Firenze 1894; 48:407432 and Lo Sperimentale Firenze 1894; 48:447452. (translated in Medical Classics 1937;1:907–912).
  • 12
    Gretsel K. Ein Fall von Anaemia splenica bei einem Kinde. Berl Klin Wochenschr 1866; 3:212214.
  • 13
    Banti G. Dell' anemia splenica. Arch Scuola Anat Pat, Firenze 1883; 124:53122.
  • 14
    Osler W. On splenic anaemia. Am J Med Sci 1900; 119:5473 and Am J Med Sci 1902; 124:751800.
  • 15
    Grannis FC. Guido Banti's hypothesis and its impact on the understanding and treatment of portal hypertension. Mayo Clinic Proceedings 1975; 50:4148.
  • 16
    Thompson WP. The pathogenesis of Banti's disease. Ann Int Med 1940; 14:255262.
  • 17
    Preble RB. Conclusions based on sixty cases of fatal gastrointestinal hemorrhage due to cirrhosis of the liver. Am J Med Sci 1900; 19:263280.
  • 18
    McIndoe AH. Vascular lesions of portal cirrhosis. Arch Pathol 1928; 5:2340.
  • 19
    Bradley SE, Ingelfinger FJ, Bradley GP. Hepatic circulation in cirrhosis of the liver. Circulation 1952; 5:419422.
  • 20
    Murray JF, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958; 24:358367.
  • 21
    Abelmann WH. Hyperdynamic circulation in cirrhosis: a historical perspective. Hepatology 1994; 20:13561358.
  • 22
    Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994; 20:13591363.
  • 23
    Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983; 244:G52G57.
  • 24
    Halvorsen JF, Myking AO. The porto-systemic collateral pattern in the rat: an angiographic and anatomic study after partial occlusion of the portal vein. Eur Surg Res 1974; 6:183195.
  • 25
    Groszmann RJ, Vorobioff J, Riley E. Splanchnic hemodynamics in portal hypertensive rats: application of γ-labeled microspheres. Am J Physiol 1982; 242:G156G160.
  • 26
    Chokjier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using γ-labeled microspheres. Am J Physiol 1981; 240:G371G375.
  • 27
    Voribioff J, Bredfeldt JE, Riley E, Groszmann RJ. Increased splanchnic blood flow in portal hypertensive rats with cirrhosis and chronic portal vein ligation [abstract]. Gastroenterology 1981; 80:1353.
  • 28
    Blanchet L, Lebrec D. Changes in splanchnic blood flow in portal hypertensive rats. Eur J Clin Invest 1982; 12:327330.
  • 29
    Menon KVN, Kamath PS. Regional and systemic hemodynamic disturbances. Clin Liver Dis 2001; 5:617627.
  • 30
    Pinzani M, Gentilini P. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension. Semin Liver Dis 1999; 19:397410.
  • 31
    Shah V. Cellular and molecular basis of portal hypertension. Clin Liver Dis 2001; 5:629644.
  • 32
    Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24:451459.
  • 33
    Møllers S, Henriksen JM. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002; 87:915.
  • 34
    Bernardi M, Calandra S, Colantoni A, Trevisani F, Raimondo ML, Sica G, Schepis F, et al. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 1998; 27:2834.